betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Suspension

RxCUI: 833461
RxNorm name: betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Suspension
Display name: betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Suspension
Full name: betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Suspension
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:04

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
calcipotriene and betamethasone dipropionate	CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE	Cosette Pharmaceuticals, Inc.	1eba330b-ce18-6b12-e063-6294a90a8763	2024-08-13	Warnings, Adverse reactions	Exact identifier rxcui: 833461
TACLONEX	CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE	LEO Pharma Inc.	757c914f-dd8d-43cc-a973-212d591af4af	2017-11-30	Warnings, Adverse reactions	Exact identifier rxcui: 833461

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
757c914f-dd8d-43cc-a973-212d591af4af	betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion	SCD	25	These highlights do not include all the information needed to use TACLONEX Topical Suspension safely and effectively. See full prescribing information for TACLONEX Topical Suspension. TACLONEX ® (calcipotriene and betamethasone dipropionate) topical suspension Initial U.S. Approval: 2006	20171130
757c914f-dd8d-43cc-a973-212d591af4af	calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Suspension	PSN	25	These highlights do not include all the information needed to use TACLONEX Topical Suspension safely and effectively. See full prescribing information for TACLONEX Topical Suspension. TACLONEX ® (calcipotriene and betamethasone dipropionate) topical suspension Initial U.S. Approval: 2006	20171130
757c914f-dd8d-43cc-a973-212d591af4af	betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Suspension	SY	25	These highlights do not include all the information needed to use TACLONEX Topical Suspension safely and effectively. See full prescribing information for TACLONEX Topical Suspension. TACLONEX ® (calcipotriene and betamethasone dipropionate) topical suspension Initial U.S. Approval: 2006	20171130
1eba330b-ce18-6b12-e063-6294a90a8763	calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Suspension	PSN	2	These highlights do not include all the information needed to use CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE TOPICAL SUSPENSION, 0.005%/0.064% safely and effectively. See full prescribing information for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE TOPICAL SUSPENSION, 0.005%/0.064% . CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE topical suspension, 0.005%/0.064% Initial U.S. Approval: 2006	20240813
1eba330b-ce18-6b12-e063-6294a90a8763	betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion	SCD	2	These highlights do not include all the information needed to use CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE TOPICAL SUSPENSION, 0.005%/0.064% safely and effectively. See full prescribing information for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE TOPICAL SUSPENSION, 0.005%/0.064% . CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE topical suspension, 0.005%/0.064% Initial U.S. Approval: 2006	20240813
1eba330b-ce18-6b12-e063-6294a90a8763	betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Suspension	SY	2	These highlights do not include all the information needed to use CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE TOPICAL SUSPENSION, 0.005%/0.064% safely and effectively. See full prescribing information for CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE TOPICAL SUSPENSION, 0.005%/0.064% . CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE topical suspension, 0.005%/0.064% Initial U.S. Approval: 2006	20240813
d61c7acb-a64f-46ee-b125-0c80d3b35585	calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Suspension	PSN	1	These highlights do not include all the information needed to use Taclonex Scalp® Topical Suspension safely and effectively. See full prescribing information for Taclonex Scalp® Topical Suspension. Initial U.S. Approval: 2006	20100818
d61c7acb-a64f-46ee-b125-0c80d3b35585	betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Suspension	SY	1	These highlights do not include all the information needed to use Taclonex Scalp® Topical Suspension safely and effectively. See full prescribing information for Taclonex Scalp® Topical Suspension. Initial U.S. Approval: 2006	20100818
d61c7acb-a64f-46ee-b125-0c80d3b35585	betamethasone 0.5 MG/ML / calcipotriene 0.05 MG/ML Topical Lotion	SCD	1	These highlights do not include all the information needed to use Taclonex Scalp® Topical Suspension safely and effectively. See full prescribing information for Taclonex Scalp® Topical Suspension. Initial U.S. Approval: 2006	20100818